Abry Partners has closed a $780 million continuation vehicle to maintain its investment in Centauri Health Solutions, a healthcare technology provider serving U.S. health plans.
The transaction, backed by funds managed by Neuberger Private Markets and Apollo S3 as co-lead investors, provided existing limited partners with optional liquidity while raising additional capital to support Centauri’s growth strategy. Abry originally acquired Centauri in 2020 through its ninth flagship buyout fund and has since supported the company’s expansion through organic initiatives and strategic acquisitions. Founded in 2014, Centauri Health Solutions provides technology, data intelligence and member engagement services that help health insurers improve revenue accuracy, quality performance and member outcomes. The company serves more than 60 million members and maintains relationships with nearly all major U.S. health insurance payers. During Abry’s ownership, Centauri acquired Secure Exchange Solutions in 2021 to add payer-provider clinical data exchange capabilities and MedAllies in 2025 to expand its clinical data platform. In early 2026, the company divested its Provider Solutions segment, sharpening its focus on payer technology and data intelligence services.
William Blair served as financial advisor to Abry on both the continuation fund transaction and the divestiture of Centauri’s Provider Solutions segment, while Kirkland & Ellis acted as legal counsel.